Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
GALNON
ID: ALA2309599
Max Phase: Preclinical
Molecular Formula: C40H46N4O6
Molecular Weight: 678.83
Molecule Type: Small molecule
Associated Items:
ID: ALA2309599
Max Phase: Preclinical
Molecular Formula: C40H46N4O6
Molecular Weight: 678.83
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Galnon
Synonyms from Alternative Forms(1):
Canonical SMILES: Cc1cc(=O)oc2cc(NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12
Standard InChI: InChI=1S/C40H46N4O6/c1-25-21-37(45)50-36-23-27(18-19-28(25)36)42-38(46)34(17-9-10-20-41)43-39(47)35(22-26-11-3-2-4-12-26)44-40(48)49-24-33-31-15-7-5-13-29(31)30-14-6-8-16-32(30)33/h5-8,13-16,18-19,21,23,26,33-35H,2-4,9-12,17,20,22,24,41H2,1H3,(H,42,46)(H,43,47)(H,44,48)/t34-,35+/m1/s1
Standard InChI Key: IKNOZZKXIDSTRN-GPOMZPHUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.83 | Molecular Weight (Monoisotopic): 678.3417 | AlogP: 6.53 | #Rotatable Bonds: 13 |
Polar Surface Area: 152.76 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.24 | CX Basic pKa: 10.20 | CX LogP: 6.04 | CX LogD: 3.44 |
Aromatic Rings: 4 | Heavy Atoms: 50 | QED Weighted: 0.09 | Np Likeness Score: -0.26 |
1. Bulaj G, Green BR, Lee HK, Robertson CR, White K, Zhang L, Sochanska M, Flynn SP, Scholl EA, Pruess TH, Smith MD, White HS.. (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities., 51 (24): [PMID:19053761] [10.1021/jm801088x] |
2. Robertson CR, Scholl EA, Pruess TH, Green BR, White HS, Bulaj G.. (2010) Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery., 53 (4): [PMID:20121116] [10.1021/jm9018349] |
Source(1):